Ramy Farid

Insider Reports History

Entity
Individual
Location
Schrodinger, Inc., 120 West 45 Th Street, 17 Th Floor, New York, NY
Signature
/s/ Donald Shum, as attorney-in-fact for Ramy Farid
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ramy Farid:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. Director American Depositary Shares 275K $17.2M $62.46 Feb 7, 2023 By Schrodinger, Inc.
Schrodinger, Inc. President & CEO, Director Common Stock 222K $6.21M $28.00 Mar 3, 2025 Direct
Vir Biotechnology, Inc. Director Common Stock 16K $151K $9.46 May 29, 2024 Direct
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16K $24.5K $1.53 May 29, 2024 Direct
Structure Therapeutics Inc. Director Ordinary Shares 3.26M Feb 7, 2023 By Schrodinger, Inc.
Schrodinger, Inc. President & CEO, Director Stock Option (right to buy) 90K Mar 3, 2025 Direct
Structure Therapeutics Inc. Director Series B Preferred Shares 0 Feb 7, 2023 By Schrodinger, Inc.

Insider Reports Filed by Ramy Farid

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SDGR Schrodinger, Inc. Mar 3, 2025 3 $0 4 Mar 4, 2025 President & CEO, Director
VIR Vir Biotechnology, Inc. May 29, 2024 3 $0 4 May 31, 2024 Director
VIR Vir Biotechnology, Inc. May 29, 2024 0 $0 3 May 31, 2024 Director
SDGR Schrodinger, Inc. Mar 4, 2024 2 $0 4 Mar 5, 2024 President & CEO, Director
SDGR Schrodinger, Inc. Feb 9, 2023 2 $0 4 Feb 10, 2023 President & CEO, Director
GPCR Structure Therapeutics Inc. Feb 7, 2023 3 $4.13M 4 Feb 9, 2023 Director
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Director
SDGR Schrodinger, Inc. Jan 4, 2023 3 -$1.14M 4 Jan 5, 2023 President & CEO, Director
SDGR Schrodinger, Inc. Feb 9, 2022 1 $0 4 Feb 9, 2022 President & CEO, Director